Literature DB >> 17643096

Renal medullary carcinoma: report of seven cases from Brazil.

Isabela C Watanabe1, Athanase Billis, Marbele S Guimarães, Marcelo Alvarenga, Amilcar C de Matos, Izilda A Cardinalli, Renee Z Filippi, Marilia G de Castro, Sueli Suzigan.   

Abstract

We report seven cases of renal medullary carcinoma collected from several institutions in Brazil. In spite of a relatively high incidence of sickle cell trait in Brazil, this is a rare tumor. All patients were males between the ages of 8 and 69 years (mean 22 years). From the collected information, the most frequent presenting symptoms were gross hematuria and flank or abdominal pain. The duration of symptoms ranged from 1 week to 5 months. Most of the tumors were poorly circumscribed arising centrally in the renal medulla. Size ranged from 4 to 12 cm (mean 7 cm) and hemorrhage and necrosis were common findings. All seven cases described showed sickled red blood cells in the tissue and six patients were confirmed to have sickle cell trait. All cases disclosed the characteristic reticular pattern consisting of tumor cell aggregates forming spaces of varied size, reminiscent of yolk sac testicular tumors of reticular type. Other findings included microcystic, tubular, trabecular, solid and adenoid-cystic patterns, rhabdoid-like cells and stromal desmoplasia. A peculiar feature was suppurative necrosis typically resembling microabscesses within epithelial aggregates. The medullary carcinoma of the 69-year-old patient was associated with a conventional clear cell carcinoma. To our knowledge, this association has not been previously reported and the patient is the oldest in the literature. The survival after diagnosis or admission ranged from 4 days to 9 months. The 8-year-old African-Brazilian patient with a circumscribed mass is alive and free of recurrence 8 years after diagnosis. This case raises the question whether a periodic search for renal medullary carcinoma in young patients who have known abnormalities of the hemoglobin gene and hematuria could result in an early diagnosis and a better survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643096     DOI: 10.1038/modpathol.3800934

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  19 in total

1.  Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications.

Authors:  Jonathan C Goldsmith; Vence L Bonham; Clinton H Joiner; Gregory J Kato; Allan S Noonan; Martin H Steinberg
Journal:  Am J Hematol       Date:  2012-02-03       Impact factor: 10.047

2.  Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.

Authors:  Chisato Ohe; Steven C Smith; Deepika Sirohi; Mukul Divatia; Mariza de Peralta-Venturina; Gladell P Paner; Abbas Agaimy; Mitual B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Maurizio Colecchia; Eva Compérat; Isabela Werneck da Cunha; Jonathan I Epstein; Anthony J Gill; Ondřej Hes; Michelle S Hirsch; Wolfram Jochum; Lakshmi P Kunju; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Gabriella Nesi; Adeboye O Osunkoya; Maria M Picken; Priya Rao; Victor E Reuter; Paulo Guilherme de Oliveira Salles; Luciana Schultz; Satish K Tickoo; Scott A Tomlins; Kiril Trpkov; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2018-03       Impact factor: 6.394

3.  Total hip arthroplasty: Concerns and precautions in sickle-cell trait.

Authors:  Francesco Pisanu; Marco Pes; Gianfilippo Caggiari; Sebastiano Ortu; Maria Luisa Satta; Veronica Amorese; Carlo Doria
Journal:  J Orthop       Date:  2019-11-27

Review 4.  Recent Advances in Renal Medullary Carcinoma.

Authors:  Yongdong Su; Andrew L Hong
Journal:  Int J Mol Sci       Date:  2022-06-26       Impact factor: 6.208

5.  Positive screening and carrier results for the England-wide universal newborn sickle cell screening programme by ethnicity and area for 2005-07.

Authors:  Allison Streetly; Radoslav Latinovic; Joan Henthorn
Journal:  J Clin Pathol       Date:  2010-07       Impact factor: 3.411

Review 6.  The changing face of renal cell carcinoma pathology.

Authors:  Hakan Aydin; Ming Zhou
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

7.  Topoisomerase II alpha status in renal medullary carcinoma: immuno-expression and gene copy alterations of a potential target of therapy.

Authors:  Roula Albadine; Wenle Wang; Noel A Brownlee; Antoun Toubaji; Athanase Billis; Perdram Argani; Jonathan I Epstein; A Julian Garvin; Rima Cousi; Edward M Schaeffer; Christian Pavlovich; George J Netto
Journal:  J Urol       Date:  2009-06-18       Impact factor: 7.450

8.  VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?

Authors:  Nathaniel E Smith; Andrea T Deyrup; Adrian Mariño-Enriquez; Jonathan A Fletcher; Julia A Bridge; Peter B Illei; George J Netto; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

9.  Renal cell cancer among African Americans: an epidemiologic review.

Authors:  Loren Lipworth; Robert E Tarone; Joseph K McLaughlin
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

10.  Response to radiation in renal medullary carcinoma.

Authors:  Alexandra M Walsh; John B Fiveash; Alyssa T Reddy; Gregory K Friedman
Journal:  Rare Tumors       Date:  2011-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.